BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 36931681)

  • 1. Secular trends of epidemiologic patterns of chronic kidney disease over three decades: an updated analysis of the Global Burden of Disease Study 2019.
    Feng X; Hou N; Chen Z; Liu J; Li X; Sun X; Liu Y
    BMJ Open; 2023 Mar; 13(3):e064540. PubMed ID: 36931681
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Global, regional, and national burden of chronic kidney disease attributable to high sodium intake from 1990 to 2019.
    Liu W; Zhou L; Yin W; Wang J; Zuo X
    Front Nutr; 2023; 10():1078371. PubMed ID: 36937353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global, regional, and national burden of chronic kidney disease attributable to high fasting plasma glucose from 1990 to 2019: a systematic analysis from the global burden of disease study 2019.
    Wei H; Ren J; Li R; Qi X; Yang F; Li Q
    Front Endocrinol (Lausanne); 2024; 15():1379634. PubMed ID: 38601204
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of high, low, and non-optimum temperatures on chronic kidney disease in a changing climate, 1990-2019: A global analysis.
    He L; Xue B; Wang B; Liu C; Gimeno Ruiz de Porras D; Delclos GL; Hu M; Luo B; Zhang K
    Environ Res; 2022 Sep; 212(Pt A):113172. PubMed ID: 35346653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global, Regional, and National Burden of Diabetes-Related Chronic Kidney Disease From 1990 to 2019.
    Deng Y; Li N; Wu Y; Wang M; Yang S; Zheng Y; Deng X; Xiang D; Zhu Y; Xu P; Zhai Z; Zhang D; Dai Z; Gao J
    Front Endocrinol (Lausanne); 2021; 12():672350. PubMed ID: 34276558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The global burden of disease attributable to ambient fine particulate matter in 204 countries and territories, 1990-2019: A systematic analysis of the Global Burden of Disease Study 2019.
    Sang S; Chu C; Zhang T; Chen H; Yang X
    Ecotoxicol Environ Saf; 2022 Jun; 238():113588. PubMed ID: 35525115
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burden of chronic kidney disease and its risk-attributable burden in 137 low-and middle-income countries, 1990-2019: results from the global burden of disease study 2019.
    Ke C; Liang J; Liu M; Liu S; Wang C
    BMC Nephrol; 2022 Jan; 23(1):17. PubMed ID: 34986789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The trend of hypertension-related chronic kidney disease from 1990 to 2019 and its predictions over 25 years: an analysis of the Global Burden of Disease Study 2019.
    Ren Y; Wang Z; Wang Q
    Int Urol Nephrol; 2024 Feb; 56(2):707-718. PubMed ID: 37542001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Global incidence and death estimates of chronic kidney disease due to hypertension from 1990 to 2019, an ecological analysis of the global burden of diseases 2019 study.
    Liu Y; He Q; Li Q; Tian M; Li X; Yao X; He D; Deng C
    BMC Nephrol; 2023 Nov; 24(1):352. PubMed ID: 38031057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The global burden of disease attributable to high body mass index in 195 countries and territories, 1990-2017: An analysis of the Global Burden of Disease Study.
    Dai H; Alsalhe TA; Chalghaf N; Riccò M; Bragazzi NL; Wu J
    PLoS Med; 2020 Jul; 17(7):e1003198. PubMed ID: 32722671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in the incidence and DALYs of schizophrenia at the global, regional and national levels: results from the Global Burden of Disease Study 2017.
    He H; Liu Q; Li N; Guo L; Gao F; Bai L; Gao F; Lyu J
    Epidemiol Psychiatr Sci; 2020 Jan; 29():e91. PubMed ID: 31928566
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the US Burden of Chronic Kidney Disease From 2002 to 2016: An Analysis of the Global Burden of Disease Study.
    Bowe B; Xie Y; Li T; Mokdad AH; Xian H; Yan Y; Maddukuri G; Al-Aly Z
    JAMA Netw Open; 2018 Nov; 1(7):e184412. PubMed ID: 30646390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Emerging patterns and trends in global cancer burden attributable to metabolic factors, based on the Global Burden of Disease Study 2019.
    Zhang Y; Ding Y; Zhu N; Mi M; Lu Y; Zheng J; Weng S; Yuan Y
    Front Oncol; 2023; 13():1032749. PubMed ID: 36741020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global burden of cardiovascular disease attributable to metabolic risk factors, 1990-2019: an analysis of observational data from a 2019 Global Burden of Disease study.
    Wu S; Xu W; Guan C; Lv M; Jiang S; Jinhua Z
    BMJ Open; 2023 May; 13(5):e069397. PubMed ID: 37173115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distributions and trends of the global burden of COPD attributable to risk factors by SDI, age, and sex from 1990 to 2019: a systematic analysis of GBD 2019 data.
    Zou J; Sun T; Song X; Liu YM; Lei F; Chen MM; Chen Z; Zhang P; Ji YX; Zhang XJ; She ZG; Cai J; Luo Y; Wang P; Li H
    Respir Res; 2022 Apr; 23(1):90. PubMed ID: 35410227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global, regional, and national burden of oesophageal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.
    GBD 2017 Oesophageal Cancer Collaborators
    Lancet Gastroenterol Hepatol; 2020 Jun; 5(6):582-597. PubMed ID: 32246941
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trends in prevalence, mortality, and morbidity associated with high systolic blood pressure in Brazil from 1990 to 2017: estimates from the "Global Burden of Disease 2017" (GBD 2017) study.
    Nascimento BR; Brant LCC; Yadgir S; Oliveira GMM; Roth G; Glenn SD; Mooney M; Naghavi M; Passos VMA; Duncan BB; Silva DAS; Malta DC; Ribeiro ALP
    Popul Health Metr; 2020 Sep; 18(Suppl 1):17. PubMed ID: 32993676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global burden of prostate cancer attributable to smoking among males in 204 countries and territories, 1990-2019.
    Zhang H; Huang D; Zhang Y; Wang X; Wu J; Hong D
    BMC Cancer; 2023 Jan; 23(1):92. PubMed ID: 36703189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Global, regional, and national disability-adjusted life-years (DALYs) for 333 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.
    GBD 2016 DALYs and HALE Collaborators
    Lancet; 2017 Sep; 390(10100):1260-1344. PubMed ID: 28919118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A systematic analysis of chronic kidney disease burden attributable to lead exposure based on the global burden of disease study 2019.
    Song J; Pan T; Xu Z; Yi W; Pan R; Cheng J; Hu W; Su H
    Sci Total Environ; 2024 Jan; 908():168189. PubMed ID: 37907111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.